Skip to main content
. 2018 Nov 6;19:306. doi: 10.1186/s12882-018-1109-9

Table 2.

Analysis of the clinical characteristics before first use of vascular access according to vascular access type

Total
(N = 529)
RC AVF
(N = 264)
BC AVF
(N = 168)
AVG
(N = 97)
P
CVC None 227 (42.9) 121 (45.8) 69 (41.1) 37 (38.1) 0.358
IJC 3 (0.6) 2 (0.8) 0 (0) 1 (1.0)
Permanent catheter 299 (56.5) 141 (53.4) 99 (58.9) 59 (60.0)
CVC duration (days) 113.4 ± 73.5 115.3 ± 68.7 112.7 ± 63.7 109.3 ± 101.4 0.891
Preoperative surveillance None 192 (36.4) 123 (46.8) 53 (31.5) 16 (16.5) < 0.001
Duplex ultrasonography 207 (39.2) 102 (38.8) 85 (50.6) 20 (20.6)
Venography 60 (11.4) 17 (6.5) 19 (13.3) 24 (24.7)
Both 69 (13.1) 21 (8.0) 11 (6.5) 37 (38.1)
Time to 1st use (days) 64.0 (14.0–124.0) 75.0 (12.0–138.0) 65.5 (8.8–122.3) 35.0 (5.0–65.0) 0.001
PTA before maturation 112 (21.2) 70 (26.5) 27 (16.1) 15 (15.5) 0.011

Values are presented as number (%), mean ± standard deviation, or median with range

AVF arteriovenous fistula, AVG arteriovenous graft, BA brachial artery, BC brachiocephalic, CVC central vein catheter, IJC internal jugular catheter, PSV peak systolic velocity, PTA percutaneous transluminal angioplasty, RC radiocephalic